Skip to main content
رجوع
PRGO logo

Perrigo Company plc

جودة البيانات: 100%
PRGO
NYSE Healthcare Drug Manufacturers - Specialty & Generic
KWD 9.69
▲ KWD 0.05 (0.52%)
القيمة السوقية: 1.33B
نطاق اليوم
KWD 9.43 KWD 9.99
نطاق 52 أسبوعًا
KWD 9.23 KWD 28.44
حجم التداول
2,496,293
متوسط 50 يوم / 200 يوم
KWD 13.28 / KWD 19.16
الإغلاق السابق
KWD 9.64

Quick Summary

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Healthcare (631 نظير)

المقياس السهم وسيط القطاع
P/E -0.9 0.2
P/B 0.5 3.0
ROE % -39.3 3.6
Net Margin % -33.5 3.8
Rev Growth 5Y % 0.7 10.0
D/E 1.4 0.2

السعر المستهدف للمحللين

Hold
KWD 21.50 +121.9%
Low: KWD 20.00 High: KWD 23.00
مكرر الربحية المستقبلي
4.25
ربحية السهم المستقبلية
KWD 2.28
نمو ربحية السهم (تقدير)
+0.0%
الإيرادات المقدّرة
4.13B

تقديرات الأرباح

الفترة تقدير ربحية السهم تقدير الإيرادات المحللون
FY2030 KWD 2.92
KWD 2.90 – KWD 2.95
4.26B 1
FY2029 KWD 2.82
KWD 2.80 – KWD 2.85
4.21B 1
FY2028 KWD 2.67
KWD 2.64 – KWD 2.69
4.20B 1

Earnings Surprises

Last 8 quarters
Quarter Est. EPS Actual EPS Surprise
2026-02-26 KWD 0.78 KWD 0.77 -1.8%
2025-11-05 KWD 0.75 KWD 0.80 +6.7%
2025-08-06 KWD 0.59 KWD 0.57 -3.4%
2025-05-07 KWD 0.56 KWD 0.60 +7.1%
2025-02-27 KWD 0.92 KWD 0.93 +1.1%
2024-11-06 KWD 0.82 KWD 0.81 -1.2%
2024-08-02 KWD 0.48 KWD 0.53 +10.4%
2024-05-07 KWD 0.24 KWD 0.29 +20.8%

Dividend History

7 yr streak

Yield

0.08%

Payout Ratio

-0.11%

Growth (3Y)

3.71%

Growth (5Y)

5.21%

Ex-Date Payment Date Amount Yield
Mar 02, 2026 Mar 24, 2026 KWD 0.29 9.40%
Nov 28, 2025 Dec 16, 2025 KWD 0.29 8.69%
Aug 29, 2025 Sep 16, 2025 KWD 0.29 4.83%
May 30, 2025 Jun 17, 2025 KWD 0.29 4.23%
Mar 07, 2025 Mar 25, 2025 KWD 0.29 4.03%
Nov 29, 2024 Dec 17, 2024 KWD 0.28 3.87%
Aug 30, 2024 Sep 17, 2024 KWD 0.28 3.78%
May 31, 2024 Jun 18, 2024 KWD 0.28 3.99%
Mar 07, 2024 Mar 26, 2024 KWD 0.28 3.69%
Nov 30, 2023 Dec 19, 2023 KWD 0.27 3.59%
Aug 31, 2023 Sep 19, 2023 KWD 0.27 3.08%
Jun 01, 2023 Jun 20, 2023 KWD 0.27 3.33%
Mar 09, 2023 Mar 28, 2023 KWD 0.27 2.90%
Dec 01, 2022 Dec 20, 2022 KWD 0.26 3.24%
Sep 01, 2022 Sep 20, 2022 KWD 0.26 2.77%
Jun 02, 2022 Jun 21, 2022 KWD 0.26 2.52%
Feb 25, 2022 Mar 17, 2022 KWD 0.26 2.75%
Dec 02, 2021 Dec 21, 2021 KWD 0.24 2.68%
Sep 02, 2021 Sep 21, 2021 KWD 0.24 2.28%
Jun 03, 2021 Jun 22, 2021 KWD 0.24 1.96%

النقاط الرئيسية

Revenue grew 0.68% annually over 5 years — modest growth
Generating 145.10M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 3.43%
Capital efficient — spends only 2.20% of revenue on capex
ROIC of 3.73% — low return on invested capital
Dividends growing 5.21% annually over 5 years

النمو

Revenue Growth (5Y)
0.68%
Revenue (1Y)-2.75%
Earnings (1Y)N/A
FCF Growth (3Y)-30.89%

الجودة

Return on Equity
-39.29%
ROIC3.73%
Net Margin-33.51%
Op. Margin8.07%

الأمان

Debt / Equity
1.35
Current Ratio2.76
Interest Coverage2.11

التقييم

P/E Ratio
-0.94
Forward P/E4.25
P/B Ratio0.45
EV/EBITDA13.90
Dividend Yield0.08%

All Fundamental Metrics

Growth
Revenue Growth (1Y) -2.75% Revenue Growth (3Y) -4.42%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 0.68% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 4.25B Net Income (TTM) -1.43B
ROE -39.29% ROA -16.70%
Gross Margin 35.14% Operating Margin 8.07%
Net Margin -33.51% Free Cash Flow (TTM) 145.10M
ROIC 3.73% FCF Growth (3Y) -30.89%
Safety
Debt / Equity 1.35 Current Ratio 2.76
Interest Coverage 2.11
Dividends
Dividend Yield 0.08% Payout Ratio -0.11%
Dividend Growth (3Y) 3.71% Dividend Growth (5Y) 5.21%
Consecutive Div Years 7 yrs
Valuation
P/E Ratio -0.94 Forward P/E 4.25
P/B Ratio 0.45 P/S Ratio 0.31
PEG Ratio 0.00 Forward PEG N/A
EV/EBITDA 13.90 Fwd EV/EBITDA 21.22
Forward P/S 0.32 Fwd Earnings Yield 23.53%
FCF Yield 10.88%
Market Cap 1.33B Enterprise Value 4.77B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 4.25B 4.37B 4.66B 4.45B 4.14B
Net Income -1.43B -171.80M -12.70M -140.60M -68.90M
EPS (Diluted) -10.29 -1.25 -0.09 -0.97 -0.98
Gross Profit 1.49B 1.54B 1.68B 1.46B 1.42B
Operating Income 343.30M 112.90M 151.90M 78.90M 410.40M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 8.54B 9.65B 10.81B 11.02B 10.43B
Total Liabilities 5.60B 5.33B 6.04B 6.18B 5.27B
Shareholders' Equity 2.94B 4.32B 4.77B 4.84B 5.15B
Total Debt 3.97B 3.62B 4.07B 4.32B 3.69B
Cash & Equivalents 531.60M 558.80M 751.30M 600.70M 1.86B
Current Assets 2.80B 2.48B 2.83B 2.72B 3.86B
Current Liabilities 1.01B 1.04B 1.59B 1.11B 1.59B